Provider
P82-20 eviCore Healthcare Specialty Utilization Management (UM) Program – Medical Oncology Drug Prior Authorization Updates for Fully Insured Commercial and Medicare Advantage Subscribers
Program effective Date: Nov 02, 2020
Search Results
Displaying 2481 - 2490 of 3700 results
Provider
P79-20 Change in Medical Necessity Criteria to InterQual® for Substance Use Disorder Admissions
Program effective Date: Nov 02, 2020
Provider
QP95-20 Commercial Pharmacy Benefit Exclusion for Jelmyto®
Program effective Date: Oct 14, 2020
Provider
QP94-20 Commercial Pharmacy Benefit Exclusion for Condylox®, Lyumjev™, Veregen® and Zilxi™
Program effective Date: Oct 14, 2020
Provider
QP103-20 Commercial Pharmacy Benefit Exclusion for Emtricitabine-Tenofovir Disoproxil Fumarate Tablet 200-300 mg
Program effective Date: Oct 28, 2020
Provider
QP104-20 Update: Cotiviti to Perform Focused and Limited Hospital Bill Validation (HBV) Services
Program effective Date: Oct 28, 2020
Provider
P83-20 eviCore Healthcare Specialty Utilization Management (UM) Program - Laboratory Management Clinical Guideline Updates for Fully Insured Commercial and Medicare Advantage Subscribers
Program effective Date: Nov 02, 2020
Provider
P77-20 2021 Medicare Product Acupuncture Benefit Changes
Program effective Date: Nov 02, 2020
Provider
QP102-20 Introducing eviCore’s new intelliPath® Technology
Program effective Date: Oct 14, 2020